<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01608048</url>
  </required_header>
  <id_info>
    <org_study_id>CZheng2012QN180</org_study_id>
    <nct_id>NCT01608048</nct_id>
  </id_info>
  <brief_title>Transcutaneous Electrical Acupoint Stimulation to Improve Pregnancy Rates for Women Undergoing in Vitro Fertilization</brief_title>
  <official_title>Transcutaneous Electrical Acupoint Stimulation to Improve Pregnancy Rates for Women Undergoing in Vitro Fertilization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wuhan General Hospital of Guangzhou Military Command</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to investigate the effect of transcutaneous electrical
      acupoint stimulation on pregnancy rates in women undergoing in vitro fertilization.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical pregnancy rate (CPR)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Live birth rate (LBR)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">384</enrollment>
  <condition>Supervision of Pregnancy Resulting From In-vitro Fertilization</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>TEAS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>EA:electro-acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous electrical acupoint stimulation (TEAS);EA</intervention_name>
    <description>TEAS group (conventional IVF + TEAS), electro-acupuncture (EA) group (conventional IVF + electro-Acu.), and control group (only conventional IVF) Parameter of TEAS or EA: frequency of 2/100 Hz；moderate electrical current. Treatments start from the day 3 of menstruation，once every two days, 30 min for each for two continuous weeks.</description>
    <arm_group_label>TEAS</arm_group_label>
    <arm_group_label>EA:electro-acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        (1) infertile women &lt; 40 years of age, undergoing a fresh IVF or intracytoplasmic sperm
        injection (ICSI) cycle; (2) be an appropriate candidate with the potential for a lower
        success rate which defined as two or more previous unsuccessful ETs (fresh or frozen); (3)
        are willing to sign an informed consent form, indicating that they are aware of the
        investigational nature of this study that is in keeping with the policies of the
        institution; (4) willing to return to the study site for their study visits. The reason for
        our inclusion criteria is that women experienced several unsuccessful OAs or ETs may easily
        accept randomization to this study, and for whom adding TEAS or EA may significantly
        improve their clinical outcomes.

        Exclusion Criteria:

        (1) major medical illnesses (like stage III heart disease, severe hypertension,
        uncontrolled diabetes mellitus, HIV positivity, severe bleeding dyscrasias, etc.) possibly
        precluding IVF or pregnancy; (2) FSH more than 20 IU/L; (3) receiving donor eggs; (4)
        cutaneous lesion of certain acupoint area; (5) having been previously participated in this
        study or having undertaken acupuncture (in whatever modality) treatment for infertility.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cui Hong Zheng, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huazhong University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cui Hong Zheng, Doctor</last_name>
    <phone>86-27-83663275</phone>
    <email>635342693@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>IVF center of Tongji Hospital,Tongji medical college,HUST</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Cui Hong Zheng, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2012</study_first_submitted>
  <study_first_submitted_qc>May 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>March 29, 2014</last_update_submitted>
  <last_update_submitted_qc>March 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Cui Hong Zheng</investigator_full_name>
    <investigator_title>assistant research fellow</investigator_title>
  </responsible_party>
  <keyword>In-vitro Fertilization</keyword>
  <keyword>transcutaneous electrical acupoint stimulation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

